Document Detail

Distinct phenotypes in mixed connective tissue disease: subgroups and survival.
MedLine Citation:
PMID:  22864236     Owner:  NLM     Status:  Publisher    
The aim of the present study was to assess the autoantibody profile, dominant clinical symptoms and cluster characteristics of different Mixed connective tissue disease (MCTD phenotypes. Two-hundred-and-one patients with MCTD were followed-up longitudinally. Five clinical parameters, Raynaud's phenomenon, pulmonary artery hypertension (PAH), myositis, interstitial lung disease (ILD), erosive arthritis and five auto-antibodies besides anti-U1RNP, antiendothelial cell antibodies (AECA), anti-CCP, anti-cardiolipin (anti-CL), anti-SSA/SSB and IgM rheumatoid factor (RF) were selected for cluster analysis. The mean age of patients was 52.9 ± 12.4 years and the mean follow-up of the disease was 12.5 ± 7.2 years. Patients were classified into three cluster groups. Cluster 1 with 77 patients, cluster 2 with 79 patients and cluster 3 with 45 patients. In cluster 1 the prevalence of PAH (55.8%; p < 0.001), Raynaud's phenomenon (92.2%; p < 0.001) and livedo reticularis (24.6%, p < 0.001) was significantly greater than in cluster 2 and 3. In cluster 2, the incidence of ILD (98.7%; p < 0.001), myositis (77.2%; p < 0.001), and esophageal dysmotility (89.8%; p < 0.001) was significantly greater than that in cluster 1 and 3. In cluster 3, anti-CCP antibodies were present in 31 of 45 patients (68.8%) with erosions. Anti-CCP antibodies were present in 37 of 42 patients (88.0%) with erosions. PAH, angina, venous thrombosis was observed in cluster 1 and pulmonary fibrosis in cluster 2, musculosceletal damage, gastrointestinal symptoms and osteoporotic fractures were most frequent in cluster 3. Cumulative survival assessment indicated cluster 1 patients having the worst prognosis. Cluster analysis is valuable to differentiate among various subsets of MCTD and useful prognostic factor regarding the disease course.
P Szodoray; A Hajas; L Kardos; B Dezso; G Soos; E Zold; J Vegh; I Csipo; B Nakken; M Zeher; G Szegedi; E Bodolay
Related Documents :
7092616 - Dystonia musculorum deformans: implications of therapeutic response to levodopa and car...
16062096 - Efficacy and safety of donepezil in the treatment of executive dysfunction in parkinson...
23097726 - Adrenal incidentalomas with supraphysiologic response to acth stimulus: a case report.
19419426 - Inter-hemispheric inhibition is impaired in mirror dystonia.
24322196 - Fructose malabsorption in children with functional digestive disorders.
14703896 - Anticopper efficacy of captopril and sodium dimercaptosulphonate in patients with wilso...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-8-3
Journal Detail:
Title:  Lupus     Volume:  -     ISSN:  1477-0962     ISO Abbreviation:  Lupus     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-8-6     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9204265     Medline TA:  Lupus     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Institute of Immunology, Oslo University Hospital, Norway.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Construction of ?-amido-indanones via formal allenamide hydroacylation-Nazarov cyclization.
Next Document:  Extraction of betulin, trimyristin, eugenol and carnosic Acid using water-organic solvent mixtures.